Search

Novavax Inc

Gesloten

SectorGezondheidszorg

10.09 1.2

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

9.75

Max

10.14

Belangrijke statistieken

By Trading Economics

Inkomsten

-44M

-53M

Verkoop

-83M

57M

K/W

Sectorgemiddelde

3.112

56.432

EPS

-0.32

Winstmarge

-94.16

Werknemers

749

EBITDA

-39M

-40M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+12.1% upside

Dividenden

By Acuity

Volgende Winsten

5 nov 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

363M

1.6B

Vorige openingsprijs

8.89

Vorige sluitingsprijs

10.09

Nieuwssentiment

By Acuity

50%

50%

120 / 339 Rangschikking in Healthcare

Novavax Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

18 sep 2026, 20:06 UTC

Novavax Inc shares are higher in Friday's trading session, recovering from mid-morning lows and maintaining a position above the 20-day moving average.

17 sep 2026, 20:02 UTC

Novavax Inc is advancing, continuing sharp gains since Wednesday, despite earlier pulling back from a session high amid broader market weakness.

16 sep 2026, 23:21 UTC

Novavax Inc's stock is modestly lower in after-market trading, following earlier volatility and currently trading below its 20-day moving average.

15 sep 2026, 22:51 UTC

Novavax Inc. shares are lower in after-market hours, reflecting broader economic concerns following a decline in the NY Empire State Manufacturing Index.

14 sep 2026, 23:36 UTC

Novavax shares are trading lower in after-market hours, following a broader decline in U.S. stocks amid rising crude oil prices and supply concerns.

11 sep 2026, 20:08 UTC

Novavax Inc. shares are higher during Friday's session, having reached a session high earlier before pulling back. No specific news was identified.

10 sep 2026, 23:01 UTC

Novavax Inc. shares are lower in after-market hours, continuing recent downward trends. The stock reached its lowest point shortly after the market reopened.

9 sep 2026, 19:46 UTC

Social Media

Novavax Inc shares are lower amid ongoing volatility following first-quarter results. The stock has faced pressure, dipping below $11.50 earlier in the session.

8 sep 2026, 19:26 UTC

Novavax Inc. shares are trading roughly flat, reflecting minimal change since Friday's close amid broader market trends. The asset remains above its 20-day moving average.

4 sep 2026, 23:15 UTC

Novavax Inc. shares are lower in after-market hours, reflecting a slight decline since Friday's close amid rising Treasury yields and interest rate expectations.

3 sep 2026, 23:05 UTC

Novavax Inc. shares are lower in after-market trading, despite remaining above their 20-day moving average and showing significant gains from a month ago.

2 sep 2026, 23:06 UTC

Novavax Inc. shares are trading roughly flat in after-market hours, with no specific news identified. The stock remains above its 20-day moving average.

1 sep 2026, 23:31 UTC

Novavax Inc. shares are lower in after-market trading, showing volatility since Tuesday's close, though the stock remains well above its 20-day moving average.

31 aug 2026, 23:01 UTC

Novavax Inc shares are higher in after-market trading, continuing a strong three-session performance. No specific news was identified to explain the movement.

28 aug 2026, 23:01 UTC

Novavax Inc shares declined in after-market trading, amid rising market expectations for an interest rate hike and upward pressure on Treasury yields.

27 aug 2026, 23:01 UTC

Novavax Inc. shares are higher in after-market trading, rebounding from earlier volatility and remaining above the 20-day moving average.

26 aug 2026, 20:08 UTC

Novavax Inc shares are lower as the biotechnology sector declines. The stock rebounded earlier in the session but has since pulled back.

25 aug 2026, 20:07 UTC

Novavax Inc shares are higher Tuesday, supported by lower Treasury yields. The stock pulled back from an intraday high but remains up since Monday.

24 aug 2026, 20:04 UTC

Novavax shares are lower today, reflecting broader market trends, with no specific company news identified. The stock remains above its 20-day moving average.

21 aug 2026, 23:31 UTC

Novavax Inc. shares declined in after-market trading, moving within a narrow range since Friday's close. The stock remains above its 20-day moving average.

20 aug 2026, 19:02 UTC

Macro Event

Novavax shares are trading lower amid negative jobless claims data, reflecting broader market fluctuations and a significant decline since Wednesday's close.

19 aug 2026, 23:51 UTC

Novavax Inc. shares are lower in after-market hours amid broader declines in biotechnology stocks, despite an earlier session peak above Wednesday's close.

17 aug 2026, 19:36 UTC

Novavax Inc is trading higher, reaching a session peak earlier today. The stock remains at the upper end of its one-month trading range.

14 aug 2026, 23:26 UTC

Novavax Inc. shares are trading roughly flat in after-market hours, remaining above the 20-day moving average and near the upper end of the one-month range.

13 aug 2026, 19:16 UTC

Novavax Inc. shares are higher today, maintaining strength above the 20-day moving average despite rising initial jobless claims reported by the Labor Department.

12 aug 2026, 23:31 UTC

Novavax Inc. shares are lower in after-market trading, reflecting a weaker trend despite earlier gains. The stock remains above its 20-day moving average.

11 aug 2026, 23:51 UTC

Novavax Inc. shares are higher in after-market trading, maintaining a position above the 20-day moving average within its one-month trading range.

10 aug 2026, 23:46 UTC

Novavax Inc. shares are lower in after-market trading, showing some volatility since Monday's close and remaining within the middle of their one-month trading range.

7 aug 2026, 19:36 UTC

News

Novavax Inc shares are higher today, supported by $57 million in second-quarter revenue and ongoing discussions with Sanofi on a COVID-19/influenza vaccine.

6 aug 2026, 23:01 UTC

News

Novavax Inc expects 2026 revenue of $235 million to $275 million. Shares are trading higher in after-market hours following the earnings call.

Peer Vergelijking

Prijswijziging

Novavax Inc Prognose

Koersdoel

By TipRanks

12.1% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 11.333 USD  12.1%

Hoogste 18 USD

Laagste 7 USD

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Novavax Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

3 ratings

1

Buy

1

Hold

1

Sell

Sentiment

By Acuity

120 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Novavax Inc

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.